据港交所文件：博瑞生物医药（苏州）股份有限公司向港交所提交上市申请书

Group 1 - The core point of the article is that Borui Biopharmaceutical (Suzhou) Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange [1] Group 2 - The company is seeking to raise capital through the public offering to support its growth and development in the biopharmaceutical sector [1] - This move indicates the company's ambition to expand its market presence and enhance its operational capabilities [1]